Edition:
India

Panacea Biotec Ltd (PNCA.NS)

PNCA.NS on National Stock Exchange of India

220.65INR
22 Sep 2017
Change (% chg)

Rs-12.95 (-5.54%)
Prev Close
Rs233.60
Open
Rs233.00
Day's High
Rs234.50
Day's Low
Rs219.00
Volume
79,505
Avg. Vol
164,715
52-wk High
Rs266.00
52-wk Low
Rs100.10

Chart for

About

Panacea Biotec Limited is a health management company. The Company's principal business activity is the manufacture of allopathic pharmaceuticals preparations. The Company's segments include Vaccines, Formulations, Research and Development; Healthcare and Real estate activities. Its Vaccines, Formulations and Research &... (more)
No analyst recommendations are available for .

Overall

Beta: 0.62
Market Cap(Mil.): Rs13,514.98
Shares Outstanding(Mil.): 61.25
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 30.89 16.23
EPS (TTM): -- -- --
ROI: -- 14.28 15.24
ROE: -- 15.57 13.84

BRIEF-India's Panacea Biotec June-qtr loss widens

* June quarter net loss 479.9 million rupees versus loss 204.9 million rupees year ago

13 Sep 2017

BRIEF-Panacea Biotec expands collaboration with Apotex to launch prasugrel in US

* Says expands collaboration with Apotex to launch prasugrel in US

11 Sep 2017

BRIEF-Panacea Biotec entered into joint collaboration agreement with Bionpharma Inc

* Entered into joint collaboration for development, license, among others for 7 complex generic pharmaceutical products with Bionpharma Inc Source text for Eikon: Further company coverage:

28 Jul 2017

Morning News Call - India, April 24

To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_04242017.pdf If you would like to receive this newsletter via email, please register at: https://forms.thomsonreuters.com/india-morning/ FACTORS TO WATCH 3:45 pm: Farm Minister Radha Mohan Singh at an event in New Delhi. LIVECHAT-COMMODITIES From copper to oil and everything in between, the Gold & Silver Club's Nik Kalsi and Phil Carr wil

24 Apr 2017

Deals of the day-Mergers and acquisitions

April 21 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday:

22 Apr 2017

Narayana Hrudayalaya to buy NewRise Healthcare

Healthcare services provider Narayana Hrudayalaya Ltd said it would buy NewRise Healthcare Private Ltd from Panacea Biotec Ltd for an enterprise value of 1.80 billion rupees ($27.87 million).

21 Apr 2017

India's Narayana Hrudayalaya to buy NewRise Healthcare

April 21 Indian healthcare services provider Narayana Hrudayalaya Ltd said it would buy NewRise Healthcare Private Ltd from Panacea Biotec Ltd for an enterprise value of 1.80 billion rupees ($27.87 million).

21 Apr 2017

BRIEF-Narayana Hrudayalaya enteres deal to buy Newrise Healthcare

* Says entered deal to buy 100 percent stake in Newrise Healthcare from Panacea Biotec and Panera Biotec

21 Apr 2017

BRIEF-Panacea Biotec launches vaccine, Easysix, for 6 preventable diseases

* Says introduces fully liquid hexavalent combination vaccine easysixtm for six preventable diseases Source text for Eikon: Further company coverage:

29 Mar 2017

Earnings vs. Estimates

No consensus analysis data available.